NN9541 / Novo Nordisk  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9541 / Novo Nordisk
NCT05870670: A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men

Completed
1
22
Japan
NNC0519-0130, Placebo
Novo Nordisk A/S
Diabetes Mellitus, Type 2
10/23
10/23
NN9541-4842, NCT05363774: A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Completed
1
162
Europe
NNC0519-0130, Placebo (NNC0519-0130)
Novo Nordisk A/S
Healthy Volunteers (Diabetes Mellitus, Type 2)
04/24
04/24
NCT06370819: A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function

Recruiting
1
36
Europe
NNC0519-0130
Novo Nordisk A/S
Diabetes Mellitus, Type 2
04/25
04/25

Download Options